Copyright Reports & Markets. All rights reserved.

Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Enzyme-Linked Immunosorbent Assay(ELISA)
    • 1.3.3 Colloidal Gold Method
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Laboratory
    • 1.4.3 Hospital
    • 1.4.4 Others
  • 1.5 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Size & Forecast
    • 1.5.1 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity (2021-2032)
    • 1.5.3 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abbexa
    • 2.1.1 Abbexa Details
    • 2.1.2 Abbexa Major Business
    • 2.1.3 Abbexa Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.1.4 Abbexa Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbexa Recent Developments/Updates
  • 2.2 AMSBIO
    • 2.2.1 AMSBIO Details
    • 2.2.2 AMSBIO Major Business
    • 2.2.3 AMSBIO Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.2.4 AMSBIO Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AMSBIO Recent Developments/Updates
  • 2.3 Biomatik
    • 2.3.1 Biomatik Details
    • 2.3.2 Biomatik Major Business
    • 2.3.3 Biomatik Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.3.4 Biomatik Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Biomatik Recent Developments/Updates
  • 2.4 Biorbyt
    • 2.4.1 Biorbyt Details
    • 2.4.2 Biorbyt Major Business
    • 2.4.3 Biorbyt Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.4.4 Biorbyt Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Biorbyt Recent Developments/Updates
  • 2.5 Beier Bio
    • 2.5.1 Beier Bio Details
    • 2.5.2 Beier Bio Major Business
    • 2.5.3 Beier Bio Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.5.4 Beier Bio Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Beier Bio Recent Developments/Updates
  • 2.6 Innovita Biological Technology
    • 2.6.1 Innovita Biological Technology Details
    • 2.6.2 Innovita Biological Technology Major Business
    • 2.6.3 Innovita Biological Technology Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.6.4 Innovita Biological Technology Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Innovita Biological Technology Recent Developments/Updates
  • 2.7 Sunlong Biotech
    • 2.7.1 Sunlong Biotech Details
    • 2.7.2 Sunlong Biotech Major Business
    • 2.7.3 Sunlong Biotech Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.7.4 Sunlong Biotech Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sunlong Biotech Recent Developments/Updates
  • 2.8 Babio
    • 2.8.1 Babio Details
    • 2.8.2 Babio Major Business
    • 2.8.3 Babio Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.8.4 Babio Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Babio Recent Developments/Updates
  • 2.9 Shandong AMBER Biotechnology
    • 2.9.1 Shandong AMBER Biotechnology Details
    • 2.9.2 Shandong AMBER Biotechnology Major Business
    • 2.9.3 Shandong AMBER Biotechnology Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.9.4 Shandong AMBER Biotechnology Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Shandong AMBER Biotechnology Recent Developments/Updates
  • 2.10 TZYBIOTECH
    • 2.10.1 TZYBIOTECH Details
    • 2.10.2 TZYBIOTECH Major Business
    • 2.10.3 TZYBIOTECH Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.10.4 TZYBIOTECH Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 TZYBIOTECH Recent Developments/Updates
  • 2.11 Fine Biotech
    • 2.11.1 Fine Biotech Details
    • 2.11.2 Fine Biotech Major Business
    • 2.11.3 Fine Biotech Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Product and Services
    • 2.11.4 Fine Biotech Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Fine Biotech Recent Developments/Updates

3 Competitive Environment: Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit by Manufacturer

  • 3.1 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Revenue by Manufacturer (2021-2026)
  • 3.3 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Manufacturer Market Share in 2025
  • 3.5 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market: Overall Company Footprint Analysis
    • 3.5.1 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market: Region Footprint
    • 3.5.2 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market: Company Product Type Footprint
    • 3.5.3 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Size by Region
    • 4.1.1 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Region (2021-2032)
    • 4.1.3 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Average Price by Region (2021-2032)
  • 4.2 North America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value (2021-2032)
  • 4.3 Europe Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value (2021-2032)
  • 4.5 South America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Type (2021-2032)
  • 5.2 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Type (2021-2032)
  • 5.3 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Application (2021-2032)
  • 6.2 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Application (2021-2032)
  • 6.3 Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Type (2021-2032)
  • 7.2 North America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Application (2021-2032)
  • 7.3 North America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Size by Country
    • 7.3.1 North America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Type (2021-2032)
  • 8.2 Europe Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Application (2021-2032)
  • 8.3 Europe Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Size by Country
    • 8.3.1 Europe Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Size by Region
    • 9.3.1 Asia-Pacific Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Type (2021-2032)
  • 10.2 South America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Application (2021-2032)
  • 10.3 South America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Size by Country
    • 10.3.1 South America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Size by Country
    • 11.3.1 Middle East & Africa Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Drivers
  • 12.2 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Market Restraints
  • 12.3 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit
  • 13.3 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Typical Distributors
  • 14.3 Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Human CVB-IgM Test Kit is a diagnostic tool for detecting the presence of IgM antibodies to Coxsackievirus B (CVB) in human blood. CVB is a single-stranded RNA virus that can cause a variety of diseases, including myocarditis, meningitis, hand-foot-mouth disease, etc. IgM antibody is the immunoglobulin produced by the body when it is first infected by a pathogen, and its presence can indicate that the body is or has been conducting an immune response to the pathogen. This test kit helps diagnose and monitor changes in CVB infection and related conditions by detecting CVB-IgM antibodies in human blood. The test results can be used for clinical medical diagnosis, treatment and monitoring of changes in CVB infection conditions.
    This report is a detailed and comprehensive analysis for global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbexa, AMSBIO, Biomatik, Biorbyt, Beier Bio, Innovita Biological Technology, Sunlong Biotech, Babio, Shandong AMBER Biotechnology, TZYBIOTECH, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Enzyme-Linked Immunosorbent Assay(ELISA)
    Colloidal Gold Method
    Others
    Market segment by Application
    Laboratory
    Hospital
    Others
    Major players covered
    Abbexa
    AMSBIO
    Biomatik
    Biorbyt
    Beier Bio
    Innovita Biological Technology
    Sunlong Biotech
    Babio
    Shandong AMBER Biotechnology
    TZYBIOTECH
    Fine Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit, with price, sales quantity, revenue, and global market share of Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit from 2021 to 2026.
    Chapter 3, the Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit.
    Chapter 14 and 15, to describe Human CVB-IgM (Coxsackievirus Type B IgM) Detection Kit sales channel, distributors, customers, research findings and conclusion.

    Buy now